Posting on behalf of NIH…
I wanted to let you know that we have just announced a Collaborative Pilot Program, “Exploration of the Diabetic Foot Ulcer Niche”, through the Diabetes Complications Consortium: https://www.diacomp.org/shared/collaborative.aspx. The purpose of this Pilot Program is to adapt and evaluate emerging techniques focused on defining cell types and subtypes and their three-dimensional context to the study of diabetic foot ulcers. Through this program we intend to fund pilot projects (up to $750,000 total costs) to multi-disciplinary teams composed of investigators with experience in agnostic, single-cell resolution technologies and clinical scientists with experience in diabetic foot ulcer biology and access to fresh human samples. These teams will perform key establishing experiments to inform future NIDDK initiatives towards the construction of an unbiased atlas of diabetic skin and foot ulcers.
Aaron C. Pawlyk, Ph.D.
Senior Advisor for Pharmacogenomics and Drug Discovery
National Institute of Diabetes and Digestive and Kidney Diseases
Building 2DEM, Room 7207
6707 Democracy Boulevard, Bethesda, MD 20892
Tel: 301-451-7299, Fax: 301-480-0475